Data from the European Randomized Study of Screening for Prostate Cancer (ERSPC) showed that from 10–20% of men had abnormal PSA levels and therefore fulfilled the current criterion for a biopsy, though only around 24% of the men in question eventually developed PCa [5]. This evidence concerns the gene KLK3 and prostate cancer.